Kunio Okamoto
Takamatsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.
Journal: JCO precision oncology
Published: September 19, 2024
Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users.
Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
Published: September 01, 2023
Conversion surgery of Stage IV gastric cancer with peritoneal dissemination after nivolumab.
Journal: International cancer conference journal
Published: March 26, 2021
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: May 08, 2020
Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer.
Journal: Investigational new drugs
Published: September 13, 2017
Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy.
Journal: Endoscopy international open
Published: July 29, 2017
Retrospective study of unplanned hospital admission for metastatic cancer patients visiting the emergency department.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 13, 2016
Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.
Journal: Clinical lung cancer
Published: January 11, 2016
Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report.
Journal: Anti-cancer drugs
Published: November 18, 2015
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
Journal: Cancer science
Published: January 09, 2015
Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 26, 2014
Last Updated: 09/26/2026